Ani Pharmaceuticals (ANIP) Total Debt (QoQ) (2012 - 2026)
Ani Pharmaceuticals (ANIP) Total Debt (QoQ) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.65 Bn | 2.15 Bn |
| 3 | Zoetis | 31.65 Bn | 29.97 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.89 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.70 Bn | 15.31 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.12 Bn | 11.59 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - |
| 10 | Ani Pharmaceuticals | 1.63 Bn | 1.27 Bn | 165.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.25% |
| Mar 31, 2026 | -1.23% |
| Dec 31, 2025 | -1.22% |
| Sep 30, 2025 | 3.63% |
| Jun 30, 2025 | -4.59% |
| Mar 31, 2025 | -0.56% |
| Dec 31, 2024 | 1.30% |
| Sep 30, 2024 | 10.16% |
| Jun 30, 2024 | 0.08% |
| Mar 31, 2024 | -4.06% |
| Dec 31, 2023 | 3.92% |
| Sep 30, 2023 | -0.07% |
| Jun 30, 2023 | -0.07% |
| Mar 31, 2023 | 0.22% |
| Dec 31, 2022 | -0.37% |
| Sep 30, 2022 | -0.07% |
| Jun 30, 2022 | -0.07% |
| Mar 31, 2022 | -0.07% |
| Dec 31, 2021 | 42.27% |
| Sep 30, 2021 | -1.33% |